JUNS (Jupiter Neurosciences, Inc.) Volume dodolan mangsa ngarep perusahaan
The projected revenue dynamics for Jupiter Neurosciences Inc (JUNS) on GURU.Markets correlate with the success of JUP-001 and its orphan drug status, while the value of 0.00 reflects the most recent figure. The sales potential within the dementia and neuroinflammation segments remains colossal. The business relies on innovations in delivering resveratrol to the brain for the therapy of migraines and Alzheimer's disease.
Rincian analitis perusahaan Jupiter Neurosciences Inc
- nilai saham lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
- statistik nilai buku emiten:
- indikator beban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Jupiter Neurosciences Inc|JUNS - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Jupiter Neurosciences Inc|JUNS - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Jupiter Neurosciences, Inc.|JUNS - Utang jangka dawa|Utang jangka cendhak perusahaan Jupiter Neurosciences|Rasio cepet jupiterneurosciences.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
JUNS - Penghasilan resik|Proyeksi bathi mangsa ngarep Jupiter Neurosciences Inc|JUNS - Periode bali modal bisnis|Pangali Forward P/E Jupiter Neurosciences, Inc.|JUNS - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Jupiter Neurosciences Inc|JUNS - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) Jupiter Neurosciences|JUNS - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan jupiterneurosciences.com|JUNS - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Jupiter Neurosciences Inc
- indikator pendapatan dodolan lan penghasilan bisnis:
Pambiji fundamental:JUNS Jupiter Neurosciences, Inc.
This indicator identifies temporary market distortions caused by one-off trades from major players in a volatile environment. The algorithm instantly captures manipulative deviations, separating speculative emotions from fundamental factors. An analysis of the organization's future sales valuation allows for the determination of the asset's current equilibrium, without excluding the risk of sudden drawdowns. The stability of this metric for Jupiter Neurosciences Inc (JUNS) is supported by long-term raw material supply contracts. Diversification of logistics chains guarantees uninterrupted production, confirming the resilience of the projected indicators.
Pesaing Jupiter Neurosciences Inc (JUNS)
Volume dodolan mangsa ngarep perusahaan BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Regencell RGC|Prakiraan volume pendapatan perusahaan AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Prakiraan volume dodolan|XENE - Prakiraan volume dodolan|VKTX: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Prakiraan volume dodolan|DNLI: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan harmonybiosciences.com (HRMY)|Biohaven - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan AMLX (amylyx.com)|Trevi Pharma (TRVI) - Volume dodolan sing dikarepake perusahaan|Praxis Corp - Prakiraan volume dodolan|Anavex Corp (AVXL) - Volume dodolan mangsa ngarep perusahaan|CBLL: Prakiraan volume dodolan|Prothena Biosciences - Pendapatan mangsa ngarep perusahaan|ALEC (alector.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan ANNX (Annexon Biosciences)|Prakiraan pendapatan perusahaan Omeros Corporation (OMER)|Neurogene Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan AC Immune S.A. ACIU|Dodolan mangsa ngarep perusahaan Voyager Therapeutics (VYGR)|Neumora - Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SCLX|Tevogen Bio Inc. (TVGN) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan ACOG|CGTX (cogrx.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan inhibikase.com (IKT)|Prakiraan pendapatan perusahaan Cassava Sciences Inc (SAVA)|Dodolan mangsa ngarep perusahaan Assertio|Prakiraan volume dodolan COYA (Coya Therapeutics, Inc.)|Prakiraan volume pendapatan perusahaan VTGN (VistaGen Therapeutics Inc)|OVID: Volume dodolan mangsa ngarep perusahaan|ABOS: Prakiraan pendapatan perusahaan|CervoMed (CRVO) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PEPG (PepGen)|Volume dodolan mangsa ngarep perusahaan RLMD (Relmada Corp)|annovisbio.com - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Pendapatan sing dikarepake perusahaan|KLTO - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan MTVA|Volume dodolan mangsa ngarep perusahaan NRXS|Volume dodolan mangsa ngarep perusahaan Helius Medical (HSDT)|Prakiraan volume dodolan PASG|Neuphoria Therapeutics - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Minerva Neurosciences, Inc. NERV|Prakiraan volume dodolan Athira Pharma ATHA|ADXN: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cortigent (CRGT)|Prakiraan volume dodolan ATXI|BCLI - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Volume dodolan sing dikarepake perusahaan|ELYM - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan intracellulartherapies.com (ITCI)|Longboard (LBPH) - Prakiraan pendapatan perusahaan|Marinus Pharmaceuticals Inc - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan NKGN|NeuroBo - Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Volume dodolan mangsa ngarep perusahaan Synaptogenix SNPX|Trevena, Inc. - Volume dodolan mangsa ngarep perusahaan|VIGL: Prakiraan pendapatan perusahaan|WENA: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Cerevel Therapeutics
